TNFRSF11A and prostate carcinoma: In addition, Chen et al. (2006) [30] studied the expression of RANK-L/RANK/OPG in primary and metastatic human prostate cancer and found that RANK-L/RANK/OPG expression was more frequently observed in skeletal metastases than in lymph node metastases.